These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2642891)

  • 21. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
    Lantelme P; Lo M; Luttenauer L; Sassard J
    Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.
    Prieto-Carrasquero MC; Kobori H; Ozawa Y; Gutiérrez A; Seth D; Navar LG
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F632-7. PubMed ID: 15870381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapy.
    Williams GH; Hollenberg NK
    Am J Med; 1985 Sep; 79(3C):3-9. PubMed ID: 2996343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
    Simões e Silva AC; Diniz JS; Pereira RM; Pinheiro SV; Santos RA
    Pediatr Res; 2006 Dec; 60(6):734-9. PubMed ID: 17065573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.
    Tuck ML; Williams GH; Dluhy RG; Greenfield M; Moore TJ
    Circ Res; 1976 Nov; 39(5):711-7. PubMed ID: 975459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Katoh K; Fukuchi S
    Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of target tissue response to angiotensin II and sodium sensitivity in Japanese patients with essential hypertension.
    Ozono R; Matsuura H; Oshima T; Ishibashi K; Ishida M; Ishida T; Watanabe M; Kajiyama G; Kambe M
    Hypertens Res; 1996 Sep; 19(3):141-5. PubMed ID: 8891741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of plasma renin activity following intracerebroventricular administration of biologically active peptides in two-kidney, one clip hypertensive rats.
    Iwata T; Hiwada K; Kokubu T
    Jpn Heart J; 1985 Jul; 26(4):567-75. PubMed ID: 3903250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic peptide in non-modulating essential hypertension.
    Luparini RL; Ferri C; Santucci A; Balsano F
    Hypertension; 1993 Jun; 21(6 Pt 1):803-9. PubMed ID: 8500861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Fisher ND; Hurwitz S; Ferri C; Jeunemaitre X; Hollenberg NK; Williams GH
    Hypertension; 1999 Sep; 34(3):388-94. PubMed ID: 10489382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of essential hypertension with low renin: responses of plasma renin activity to various stimulation tests in essential hypertension.
    Honda M; Ueda Y; Tsuchiya M; Izumi Y; Watanabe H; Shiratsuchi T; Hatano M
    Jpn Circ J; 1978 May; 42(5):613-9. PubMed ID: 212618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
    Wang JL; Cheng HF; Harris RC
    Hypertension; 1999 Jul; 34(1):96-101. PubMed ID: 10406830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact.
    Derkx FH; van den Meiracker AH; Fischli W; Admiraal PJ; Man in't Veld AJ; van Brummelen P; Schalekamp MA
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):602-9. PubMed ID: 1873015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
    Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
    Bragat AC; Blumenfeld J; Sealey JE
    J Hypertens; 1997 May; 15(5):459-65. PubMed ID: 9169997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.